Status:
COMPLETED
Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Novartis
Conditions:
Thalassemia
Sickle Cell Disease
Eligibility:
All Genders
6+ years
Brief Summary
The investigators' primary objective is to study prevalences of myocardial iron overload, defined as a cardiac T2\*\< 20 ms, in 3 populations of multiply transfused patients, affected with thalassemia...
Detailed Description
The inevestigators' primary objective is to study prevalences of myocardial iron overload, defined as a cardiac T2\*\< 20 ms, in 3 populations of multiply transfused patients, affected with thalassemi...
Eligibility Criteria
Inclusion
- Thalassemia, sickle cell disease, myelodysplasia
- having received in the past year \> 8 erythrocyte concentrates
- \> 6 years of age
Exclusion
- preexisting cardiac disease
Key Trial Info
Start Date :
March 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT01911871
Start Date
March 1 2012
End Date
March 1 2015
Last Update
April 10 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Necker Enfants Malades
Paris, France, 75015